Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: The anticancer drug sunitinib promotes autophagy and protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration.

Journal of neurovirology·2026
Same author

Drug tissue concentration and STAT3 modulation as determinants of tofacitinib response in ulcerative colitis.

Journal of Crohn's & colitis·2025
Same author

Ectopic USP15 expression inhibits HIV-1 transcription involving changes in YY1 deubiquitination and stability.

Frontiers in cellular and infection microbiology·2024
Same author

Evaluation of a Novel Smart Capsule Bacterial Detection System Device for Diagnosis of Small Intestinal Bacterial Overgrowth.

Neurogastroenterology and motility·2024
Same author

Correction: Tat expression led to increased histone 3 tri-methylation at lysine 27 and contributed to HIV latency in astrocytes through regulation of MeCP2 and Ezh2 expression.

Journal of neurovirology·2023
Same author

Metformin Treatment Leads to Increased HIV Transcription and Gene Expression through Increased CREB Phosphorylation and Recruitment to the HIV LTR Promoter.

Aging and disease·2023
Same journal

Deletion of Fbxo25 causes excessive repetitive behavior, impaired recognition memory, reduced dendritic complexity, and aberrant protein expression in mice.

Progress in neurobiology·2026
Same journal

Neuropsychiatric Disease Mechanisms and Interventions. from 22q11.2 Deletion Syndrome Experimental Studies.

Progress in neurobiology·2026
Same journal

REM sleep as a dummy-model of the world: A theoretical framework.

Progress in neurobiology·2026
Same journal

CA3 transiently modulates spatial representation in CA1.

Progress in neurobiology·2026
Same journal

Love, death, and oxytocin: In memory of Larry Young.

Progress in neurobiology·2026
Same journal

Assessing peripheral oxytocin and cortisol levels and epigenetic variations of oxytocin receptor and glucocorticoid receptor genes in school-aged preterm-born children.

Progress in neurobiology·2026
See all related articles

Related Experiment Video

Updated: Mar 22, 2026

A Rat Model of EcoHIV Brain Infection
08:48

A Rat Model of EcoHIV Brain Infection

Published on: January 21, 2021

3.9K

HIV/neuroAIDS biomarkers.

Pejman Rahimian1, Johnny J He1

  • 1Department of Cell Biology and Immunology, Graduate School of Biomedical Sciences, University of North Texas Health Science Center, Fort Worth, TX 76107, United States.

Progress in Neurobiology
|April 17, 2016
PubMed
Summary
This summary is machine-generated.

Biomarkers are crucial for diagnosing and monitoring HIV/neuroAIDS, offering objective insights beyond clinical symptoms. Research focuses on cerebrospinal fluid, blood, and neuroimaging biomarkers for improved disease management.

Keywords:
BiomarkersBloodCSFHIV/neuroAIDSNeuroimaging

More Related Videos

Quantification of Cerebral Vascular Architecture using Two-photon Microscopy in a Mouse Model of HIV-induced Neuroinflammation
10:04

Quantification of Cerebral Vascular Architecture using Two-photon Microscopy in a Mouse Model of HIV-induced Neuroinflammation

Published on: January 12, 2016

9.7K
Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
17:16

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

11.0K

Related Experiment Videos

Last Updated: Mar 22, 2026

A Rat Model of EcoHIV Brain Infection
08:48

A Rat Model of EcoHIV Brain Infection

Published on: January 21, 2021

3.9K
Quantification of Cerebral Vascular Architecture using Two-photon Microscopy in a Mouse Model of HIV-induced Neuroinflammation
10:04

Quantification of Cerebral Vascular Architecture using Two-photon Microscopy in a Mouse Model of HIV-induced Neuroinflammation

Published on: January 12, 2016

9.7K
Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
17:16

Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring

Published on: December 9, 2010

11.0K

Area of Science:

  • Neurology
  • Infectious Diseases
  • Biomarker Discovery

Background:

  • HIV infection frequently leads to neurological complications (HIV/neuroAIDS), affecting cognition and motor skills.
  • Current diagnostic methods rely on descriptive assessments, lacking sensitivity for disease monitoring and treatment response.
  • The aging HIV population increases vulnerability to neurodegenerative diseases, highlighting the need for objective markers.

Purpose of the Study:

  • To review current knowledge on biomarker discovery for HIV/neuroAIDS.
  • To emphasize the limitations of current diagnostic methods and the need for objective measures.
  • To explore the potential of various biomarker classes in understanding HIV-associated neurologic injury.

Main Methods:

  • Review of existing literature on HIV/neuroAIDS biomarkers.
  • Focus on cerebrospinal fluid, blood, and neuroimaging biomarkers.
  • Analysis of the role of biomarkers in diagnosis, progression, and treatment response.

Main Results:

  • Biomarkers offer quantitative and objective measures compared to clinical assessments.
  • Biomarkers can help elucidate the impact of comorbidities on HIV/neuroAIDS.
  • Three main classes of biomarkers are under investigation: CSF, blood, and neuroimaging.

Conclusions:

  • Reliable biomarkers are essential for precise diagnosis and management of HIV/neuroAIDS.
  • Biomarker research is critical for an aging HIV population at risk for neurodegeneration.
  • Continued efforts in biomarker discovery will improve patient outcomes and disease understanding.